First Time Loading...
A

Aurisco Pharmaceutical Co Ltd
SSE:605116

Watchlist Manager
Aurisco Pharmaceutical Co Ltd
SSE:605116
Watchlist
Price: 23.35 CNY -1.44% Market Closed
Updated: May 17, 2024

Cash Flow Statement

Cash Flow Statement
Aurisco Pharmaceutical Co Ltd

Rotate your device to view
Cash Flow Statement
Currency: CNY
Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023
Operating Cash Flow
Cash Taxes Paid
(3)
6
12
10
22
25
35
28
34
31
22
36
23
19
33
Change in Working Capital
(185)
(140)
(156)
(164)
(179)
(196)
(194)
(218)
(241)
(255)
(282)
(292)
(297)
(309)
(337)
Cash from Operating Activities
198
N/A
226
+14%
255
+13%
215
-16%
220
+2%
172
-22%
171
-1%
202
+18%
203
+1%
185
-9%
130
-30%
166
+28%
221
+33%
242
+9%
367
+52%
Investing Cash Flow
Capital Expenditures
(91)
(88)
(112)
(159)
(186)
(182)
(185)
(251)
(255)
(267)
(251)
(216)
(207)
(233)
(287)
Other Items
(42)
19
49
2
(1)
(22)
(31)
(12)
23
(27)
(17)
(41)
(41)
10
69
Cash from Investing Activities
(133)
N/A
(69)
+48%
(63)
+8%
(157)
-148%
(187)
-19%
(204)
-9%
(216)
-6%
(262)
-21%
(232)
+12%
(293)
-26%
(268)
+9%
(257)
+4%
(248)
+3%
(223)
+10%
(218)
+2%
Financing Cash Flow
Net Issuance of Debt
0
0
0
0
0
0
0
0
3
6
6
36
38
39
72
Cash Paid for Dividends
0
0
(36)
(36)
0
(84)
(48)
(48)
0
(50)
(52)
(52)
(53)
(68)
(67)
Other
(36)
(35)
311
283
318
318
(26)
(4)
0
0
(5)
1
1
30
29
Cash from Financing Activities
(36)
N/A
(35)
+3%
275
N/A
247
-10%
282
+14%
234
-17%
(74)
N/A
(52)
+29%
(48)
+9%
(47)
+1%
(52)
-10%
(15)
+71%
(14)
+9%
1
N/A
35
+2 438%
Change in Cash
Effect of Foreign Exchange Rates
(5)
(6)
(10)
(6)
(9)
(9)
(7)
(4)
(3)
2
5
4
5
9
4
Net Change in Cash
24
N/A
116
+393%
456
+293%
298
-35%
306
+3%
192
-37%
(127)
N/A
(117)
+8%
(79)
+32%
(154)
-94%
(185)
-20%
(102)
+45%
(36)
+65%
29
N/A
188
+546%
Free Cash Flow
Free Cash Flow
107
N/A
138
+29%
143
+4%
56
-61%
34
-40%
(10)
N/A
(15)
-42%
(49)
-236%
(52)
-6%
(82)
-57%
(122)
-49%
(50)
+59%
14
N/A
9
-38%
80
+812%

See Also

Discover More